home / stock / igc / igc news

IGC News and Press, India Globalization Capital Inc. From 11/17/25

Stock Information
Company Name: India Globalization Capital Inc.
Stock Symbol: IGC
Market: NYSE
Website: igcinc.us
Menu
IGC IGC Quote IGC Short IGC News IGC Articles IGC Message Board
Get IGC Alerts

News, Short Squeeze, Breakout and More Instantly...
IGC - IGC Pharma GAAP EPS of -$0.02 in-line, revenue of $0.19M misses by $0.13M

2025-11-17 08:45:15 ET More on IGC Pharma Seeking Alpha’s Quant Rating on IGC Pharma Historical earnings data for IGC Pharma Financial information for IGC Pharma Read the full article on Seeking Alpha For further details see: IGC Pharma GAA...
IGC - IGC Pharma Reports Accelerated Q2 Progress and Strengthened Financial Focus: CALMA Trial Passes 50% Enrollment Milestone, Strategic Divestiture Optimizes Capital

Company Accelerates Phase 2 Alzheimer's Program and Gains National Institute on Aging (NIA) Recognition for AI Leadership POTOMAC, MARYLAND / ACCESS Newswire / November 17, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company leverag...

IGC - Here are the major earnings before the open Monday

2025-11-16 18:00:05 ET Major earnings expected before the bell on Monday include: XPeng ( XPEV ) JinkoSolar Holding Co., Ltd. ( JKS ) Luckin Coffee ( OTCPK:LKNCY ) Helmerich & Payne ( HP ) Niu Technologies ( NIU ) Read the full article o...

IGC - USPTO Grants IGC Pharma Patent Covering IGC-AD1 for Novel Composition Targeting Alzheimer's Disease and Central Nervous System Disorders

POTOMAC, MARYLAND / ACCESS Newswire / November 13, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging Artificial Intelligence ("AI") to develop innovative treatments for Alzheimer's disease, today announced tha...
IGC - IGC Pharma to Host Mid-Year Fiscal 2026 Shareholder Update Call on November 17, 2025

POTOMAC, MARYLAND / ACCESS Newswire / November 10, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced that the Company will host a co...

IGC - IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline

POTOMAC, MARYLAND / ACCESS Newswire / November 3, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced an expansion of its AI-powered i...

IGC - IGC Pharma Advances to Semi-Finals in the Alzheimer's Insights AI Prize with "AHA: Agentic Harmonization Assistant"

POTOMAC, MD / ACCESS Newswire / October 22, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced that its project "AHA: Agentic Harmoni...
IGC - IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida's Department of Psychiatry and Behavioral Neurosciences

POTOMAC, MD, 1734 / ACCESS Newswire / October 14, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced the expansion of its ongoing Pha...

IGC - IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders

POTOMAC, MARYLAND / ACCESS Newswire / October 10, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced that during its Annual Meeting o...

IGC - IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease

IGC-1C Targets Tau Protein's Liquid-Liquid Phase Separation (LLPS), Posing a Novel Threat to Neurotoxic Tangles; High Binding Affinity Confirmed POTOMAC, MD, 1734 / ACCESS Newswire / October 7, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical...
Previous 10 Next 10